Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia, Myeloid, Acute 35Leukemia 33Myelodysplastic Syndromes 23Lymphoma, Non-Hodgkin 19Lymphoma 13Leukemia, Lymphocytic, Chronic, B-Cell 13Hodgkin Disease 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Leukemia, Biphenotypic, Acute 8Burkitt Lymphoma 7Recurrence 6Multiple Myeloma 6Leukemia, Myelomonocytic, Juvenile 6Leukemia, Myelomonocytic, Chronic 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Accelerated Phase 5Hematologic Neoplasms 5Congenital Abnormalities 5Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma, B-Cell 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Anemia, Refractory, with Excess of Blasts 4Primary Myelofibrosis 3Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3

Interventions

midostaurin 2selinexor 1pegfilgrastim 1glofitamab 1Topotecan 1Rituximab 1Prednisone 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Methylprednisolone 1Immunologic Techniques 1Ifosfamide 1Flow Cytometry 1Etoposide 1Dexamethasone 1Clofarabine 1Carboplatin 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Aggression × Clofarabine × Lymphoid × Clear all
NCT00201669 2017-12-06

A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
6 enrolled
Lymphoid

Aggression, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡